Bioventus shares rise after Medicare reverses reimbursement cuts

Investing.com -- Bioventus Inc. shares climbed as much as 13% on Monday, reaching the highest intraday level since 2024. The increase followed an announcement that the Centers for Medicare & Medicaid Services reversed previously issued reimbursement cuts for the company's non-invasive bone growth stimulators.

You May Also Be Interested In

• PhillipCapital Downgrades SRF Ltd (SRF:IN) to Neutral (3)
• Macquarie Upgrades Seatrium Ltd (STM:SP) to Outperform
• JPMorgan Upgrades BOC Hong Kong (2388:HK) (BHKLY) to Overweight